What makes us decide to play it safe or take a risk? Scientists presented research today identifying regions and functions of the brain involved in such decisions to provide fresh insights into how humans explore the unknown. These findings also add to a relatively new area of inquiry — neuroeconomics and the study of economic behavior. The research was presented at Neuroscience 2011, the Society for Neuroscience's annual meeting and the world's largest source of emerging news about brain science and health.
Specifically, today's new findings show that:
The brain chemical serotonin may be involved in risky decision-making. Researchers found that when certain serotonin receptors are blocked, people are less likely to take a gambling risk (Julian Macoveanu, PhD, abstract 931.10, see summary attached).
Other recent findings discussed show that:
Brain cells in the orbitofrontal cortex of the monkey brain assign values to different goods. The activity of these cells adapts to the range of values presented and is independent of the value of alternative options (Camillo Padoa-Schioppa, PhD, see attached speaker's summary).
The brain circuit connecting the cortex and basal ganglia is involved in "deciding" which behavior to pursue. Studying this circuit yields new information about emotional decision-making and insights into certain neurological disorders, like obsessive-compulsive-spectrum disorders and addiction (Ann Graybiel, PhD, see attached speaker's summary).
"These studies help deepen our understanding of the highly complex mechanisms involved in decision-making," said press conference moderator Michael Platt, PhD, of Duke University, an expert in cognitive behavior and the brain. "Such research is not only helping us understand how and why we make the choices we do, but it also may lead to more effective interventions for some of the many brain disorders that are characterized by poor decision-making."
View full release and summaries at www.sfn.org/newsroom.
This research was supported by national funding agencies, such as the National Institutes of Health, as well as private and philanthropic organizations.
Kat Snodgrass | EurekAlert!
How to design city streets more fairly
18.05.2020 | Mercator Research Institute on Global Commons and Climate Change (MCC) gGmbH
Insects: Largest study to date confirms declines on land, but finds recoveries in freshwater – Highly variable trends
24.04.2020 | Deutsches Zentrum für integrative Biodiversitätsforschung (iDiv) Halle-Jena-Leipzig
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering